Hologic’s HOLX progress in the domestic and international markets, a strong pipeline of products and continued solid performance of the Molecular Diagnostics segment bolster our confidence. The stock ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
MARLBOROUGH, Mass. & NEW YORK & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) today announced that it has entered into a definitive agreement to be acquired by funds ...
Women’s health medical device maker, Hologic HOLX, is struggling with continued softness in its core Breast Health segment. Sales fell 6.2% in the fiscal 2025 second quarter due to weaker sales of ...
Hologic HOLX offers a wide range of diagnostic products to help in the screening and diagnosis of human disease. Although the performance of the Diagnostics segment in recent quarters has been ...
Thought LeadersSarah Smith and Tim SimpsonSenior Marketing Manager and General ManagerHologic In celebration of International Women's Day 2024, we're honored to host Tim Simpson and Sarah Smith from ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Hologic HOLX is set to release fourth-quarter fiscal 2025 results on Nov. 3, after the closing bell. The Zacks Consensus Estimate for fiscal fourth-quarter earnings per share (EPS) suggests an 8.9% ...
Global Core Needle Biopsy Devices Market Trends 2023: This research elaborates on the industrial trends for topmost industries for the insights on Core Needle Biopsy Devices market, observes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results